Your browser doesn't support javascript.
loading
Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
Besse, Lenka; Sedlarikova, Lenka; Kryukov, Fedor; Nekvindova, Jana; Radova, Lenka; Slaby, Ondrej; Kuglik, Petr; Almasi, Martina; Penka, Miroslav; Krejci, Marta; Adam, Zdenek; Pour, Ludek; Sevcikova, Sabina; Hajek, Roman.
Afiliación
  • Besse L; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
  • Sedlarikova L; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
  • Kryukov F; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Hematooncology, Faculty of Medicine University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic.
  • Nekvindova J; Institute of Clinical Biochemistry and Diagnostics, Faculty of Medicine and Faculty Hospital in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
  • Radova L; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Slaby O; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Kuglik P; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Almasi M; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
  • Penka M; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
  • Krejci M; Department of Internal Medicine-Hematooncology, University Hospital Brno, Brno, Czech Republic.
  • Adam Z; Department of Internal Medicine-Hematooncology, University Hospital Brno, Brno, Czech Republic.
  • Pour L; Department of Internal Medicine-Hematooncology, University Hospital Brno, Brno, Czech Republic.
  • Sevcikova S; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
  • Hajek R; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic; Department of Hematooncology, Faculty of Medicine University of Ostrava and University Hospita
PLoS One ; 10(9): e0137294, 2015.
Article en En | MEDLINE | ID: mdl-26389804
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Plasmáticas / Médula Ósea / Regulación Neoplásica de la Expresión Génica / MicroARNs / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Plasmáticas / Médula Ósea / Regulación Neoplásica de la Expresión Génica / MicroARNs / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Estados Unidos